Potentialities of adjuvant endocrine therapy for breast cancer (Part II)

Potentialities of adjuvant endocrine therapy for breast cancer (Part II)

Potentialities of adjuvant endocrine therapy for breast cancer (Part II)

Bibliographic Details
Main Authors:	N. Yu. Dobrovolskaya, E. K. Vvoznyi, Yu. M. Bychkov
Format:	Article
Language:	Russian
Published:	ABV-press 2014-09-01
Series:	Опухоли женской репродуктивной системы
Online Access:	https://ojrs.abvpress.ru/ojrs/article/view/378

Similar Items

Adjuvant endocrinotherapy of breast cancer (part I)
by: N. Yu. Dobrovolskaya, et al.
Published: (2014-09-01)

Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients
by: Roberta Rosso, et al.
Published: (2023-01-01)

Understanding adjuvant endocrine therapy persistence in breast Cancer survivors
by: Leah K. Lambert, et al.
Published: (2018-07-01)

Compliance to adjuvant endocrine therapy and survival in breast cancer patients.
by: Chaido Chamalidou, et al.
Published: (2023-01-01)

Healthcare Provider Perspectives on Adherence to Adjuvant Endocrine Therapy after Breast Cancer
by: Leah K. Lambert, et al.
Published: (2021-04-01)

It’s not an easy fix: Adherence to adjuvant endocrine therapy after breast cancer
by: Leah K. Lambert, et al.
Published: (2021-05-01)

The Potential Role of Nutraceuticals as an Adjuvant in Breast Cancer Patients to Prevent Hair Loss Induced by Endocrine Therapy
by: Giorgio Dell’Acqua, et al.
Published: (2020-11-01)

Complexities in Adjuvant Endocrine Therapy for Breast Cancer in Female-to-Male Transgender Patients
by: Shoko Sato, et al.
Published: (2024-02-01)

Extended Adjuvant Endocrine Therapy in Early Breast Cancer Patients—Review and Perspectives
by: Inga Bekes, et al.
Published: (2023-08-01)

Extended adjuvant endocrine therapy in a longitudinal cohort of young breast cancer survivors
by: Tal Sella, et al.
Published: (2023-04-01)

Adverse effects of adjuvant endocrine therapy
by: E. I. Kovalenko, et al.
Published: (2018-07-01)

Follow-up Routines Matter for Adherence to Endocrine Therapy in the Adjuvant Setting of Breast Cancer
by: Carolina Aurell, et al.
Published: (2024-04-01)

Potentially Modifiable Factors Associated with Adherence to Adjuvant Endocrine Therapy among Breast Cancer Survivors: A Systematic Review
by: Kirsti I. Toivonen, et al.
Published: (2020-12-01)

Prevalence and determinants of adherence to oral adjuvant endocrine therapy among breast cancer patients in Singapore
by: Eskinder Eshetu Ali, et al.
Published: (2017-01-01)

Women’s coping strategies during the first three months of adjuvant endocrine therapy for breast cancer
by: Susanne Ahlstedt Karlsson, et al.
Published: (2020-03-01)

Identifying determinants of adherence to adjuvant endocrine therapy following breast cancer: A systematic review of reviews
by: Adam Todd, et al.
Published: (2024-02-01)

Oncologists’ perspectives on adherence/non-adherence to adjuvant endocrine therapy and management strategies in women with breast cancer
by: Eraso, Yolanda
Published: (2019)

Side Effects and Its Management in Adjuvant Endocrine Therapy for Breast Cancer: A Matter of Communication and Counseling
by: Aina Johnsson, et al.
Published: (2023-01-01)

Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests
by: Mariarosaria Saponaro, et al.
Published: (2022-11-01)

Level of Combined Estrogen and Progesterone Receptor Expression Determines the Eligibility for Adjuvant Endocrine Therapy in Breast Cancer Patients
by: Jee Hyun Ahn, et al.
Published: (2021-10-01)

Perceived New Normal and Inner Strength on Quality of Life in Breast Cancer Patients Receiving Adjuvant Endocrine Therapy
by: Sujin Ha, et al.
Published: (2021-01-01)

Adjuvant endocrine therapy in patients with estrogen receptor-low positive breast cancer: A prospective cohort study
by: Yuxin Xie, et al.
Published: (2022-12-01)

Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy endocrine therapy alone in patients with HR+/HER2− early breast cancer
by: Dennis J. Slamon, et al.
Published: (2023-05-01)

Current feasibility of endocrine therapy for breast cancer
by: I. V. Vysotskaya
Published: (2014-07-01)

PHARMACOECONOMIC ANALYSIS OF DOCETAXEL IN THE ADJUVANT THERAPY OF BREAST CANCER
by: R. I. Yagudina, et al.
Published: (2015-03-01)

Appraising Adjuvant Endocrine Therapy in Hormone Receptor Positive HER2-Negative Breast Cancer—A Literature Review
by: Danilo Giffoni de Mello Morais Mata, et al.
Published: (2022-07-01)

Longitudinal Trends in Illness Perception and Depression during Adjuvant Breast Cancer Endocrine Therapy: A Prospective Observational Study
by: Seul Ki Park, et al.
Published: (2021-09-01)

Development of the HT&Me intervention to support women with breast cancer to adhere to adjuvant endocrine therapy and improve quality of life
by: Sarah-Jane F. Stewart, et al.
Published: (2023-08-01)

Adjuvant therapy for early breast cancer
by: I. V. Vysotskaya
Published: (2014-07-01)

American society of clinical oncology update on the role of bisphosphonates and bone health issues in women with breast cancer Part II. Bisphosphonates in the adjuvant therapy of breast cancer
by: I. V. Vysotskaya
Published: (2014-09-01)

Which adjuvant endocrine therapy for ER-positive non-metastatic breast cancer? EBCTCG-2000 update: Tamoxifen, castration, LHRH-agonists
by: Davies, C, et al.
Published: (2002)

The renaissance of endocrine therapy in hormone sensitive breast cancer
by: article Editorial
Published: (2019-12-01)

Codevelopment of a Text Messaging Intervention to Support Adherence to Adjuvant Endocrine Therapy in Women With Breast Cancer: Mixed Methods Approach
by: Sophie M C Green, et al.
Published: (2023-05-01)

Comparison of distress in breast cancer survivors treated with different adjuvant endocrine therapies: a single-centre cross-sectional study
by: Tulay Kus, et al.
Published: (2017-07-01)

NEOADJUVANT ENDOCRINE THERAPY FOR PATIENTS WITH ESTROGEN-RECEPTOR-POSITIVE BREAST CANCER
by: V. F. Semiglazov, et al.
Published: (2018-07-01)

Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR +) breast cancer
by: Julia Foldi, et al.
Published: (2023-06-01)

Corrigendum to Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2− early breast cancer
Published: (2023-09-01)

Adjuvant therapy in premenopausal women with hormone-dependent breast cancer
by: V. F. Semiglazov, et al.
Published: (2018-11-01)

Novel strategies to improve the endocrine therapy of breast cancer
by: Aurelio Bartolome Castrellon
Published: (2017-05-01)

Taxanes in adjuvant and neoadjuvant therapy for breast cancer
by: S. V. Limareva
Published: (2014-08-01)